A newly understood class of carcinogens, like particulate air pollution, doesn't cause DNA mutations (the 'seed'). Instead, these 'inflammagens' create a specific type of chronic inflammation that acts as fertile 'soil,' encouraging pre-existing, dormant cancer cells to awaken and grow.

The unbalanced, short-wavelength-heavy spectrum of common LED lights, which lacks counteracting long-wavelength red light, may cause systemic mitochondrial dysfunction. Some scientists believe this is a major public health issue with a potential impact comparable to that of asbestos.

Dr. Andrew Weil posits that diseases like Parkinson's and ALS are largely caused by environmental factors, such as agrochemicals and plastics, rather than being purely genetic or familial as is commonly believed.

New research using epigenomic analysis found a strong link between the 80% rise in youth colon cancer and Picloram, a widely used herbicide from the 1960s. The chemical's persistence in the environment and its effect on gene expression appear to be a primary cause, showing how legacy chemicals create modern health crises.

Unlike treating active diseases, prevention aims to make something *not* happen, which requires long, large, and expensive trials. Cancer also lacks a simple predictive biomarker like cholesterol for heart disease, forcing researchers to wait for the disease itself to appear as the endpoint.

Despite testing millions of compounds, high-throughput screening methods suffer from enormous false-positive rates. The actual predictive value for a re-synthesized molecule is extremely low, creating an opening for high-fidelity AI models to provide cleaner, more reliable predictions.

Chronic illnesses like cancer, heart disease, and Alzheimer's typically develop over two decades before symptoms appear. This long "runway" is a massive, underutilized opportunity to identify high-risk individuals and intervene, yet medicine typically focuses on treatment only after a disease is established.

Vaping introduces a high concentration of volatile compounds into lung tissue, many approved for ingestion but not inhalation. This accelerated damage leads scientists to anticipate a wave of much earlier lung cancer diagnoses, potentially in patients as young as 30-35, a significant shift from traditional smoking timelines.

Unlike the EU's strict approval process for new chemicals, the U.S. allows companies to self-declare novel compounds as "Generally Recognized as Safe" (GRAS). This has resulted in tens of thousands of chemicals in the U.S. food system that are not permitted in the EU, contributing to the chronic disease crisis.